Classys Selects Actress Lee Na-young as New Model for Shrink
[Asia Economy Reporter Hyunseok Yoo] Classys announced on the 12th that actress Lee Na-young has been selected as the exclusive model for its flagship product, Shurink.
A company official stated, “Actress Lee Na-young’s elegant and sophisticated image has a charm that appeals to all generations,” and added, “She was evaluated as the best fit to express the advantages of Shurink’s various cartridges,” explaining the reason for selecting her as the model.
It is important for medical aesthetic devices to maintain high trust from both medical professionals and the general public. Shurink is a medical device used for eyebrow lifting, improving elasticity of the face, abdomen, and thighs, as well as reducing wrinkles around the eyes, mouth, and neck. The company is expanding expert marketing through various clinical trials and published papers.
Hot Picks Today
"Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Additionally, as Shurink’s cumulative domestic sales have exceeded 3,500 units, product improvements such as continuous upgrades are being carried out to strengthen the brand. Advertisements featuring the new model Lee Na-young will be released on TV commercials and various online and offline platforms, which is expected to help consumers intuitively understand Shurink’s competitiveness.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.